TRANSTHYRETIN AMYLOID CARDIOMYOPATHY TREATMENT WITH AN ANTISENSE OLIGONUCLEOTIDE INHIBITOR OF TTR (ISIS-TTR RX)

被引：0
|
作者：
Benson, M. D. [1 ]
Ackermann, E. J. [2 ]
Monia, B. [2 ]
机构：
[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[2] ISIS Pharmaceut Inc, Carlsbad, CA USA
来源：
CARDIOLOGY | 2015年 / 131卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
221
引用
收藏
页码：233 / 233
页数：1
相关论文
共 50 条
  • [1] Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis
    Merrill D Benson
    Elizabeth J Ackermann
    Brett P Monia
    Orphanet Journal of Rare Diseases, 10 (Suppl 1)
  • [2] A phase 3 clinical trial with ISIS-TTRRx, a 2nd-generation antisense oligonucleotide targeting transthyretin (TTR), for the treatment of TTR amyloid cardiomyopathy
    Helen Millns
    Rito Bergemann
    Elizabeth Ackermann
    Brett Monia
    Mary Ann Lukas
    Orphanet Journal of Rare Diseases, 10 (Suppl 1)
  • [3] Safety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy
    Benson, Merrill D.
    Dasgupta, Noel R.
    Rissing, Stacy M.
    Smith, Jessica
    Feigenbaum, Harvey
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2017, 24 (04): : 219 - 225
  • [4] POTENTIAL REVERSAL OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY WITH TTR SPECIFIC ANTISENSE OLIGONUCLEOTIDE THERAPY
    Dasgupta, Noel Rakhi
    Benson, Merrill D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 660 - 660
  • [5] IMPROVED SURVIVAL OF PATIENTS WITH TRANSTHYRETIN AMYLOID CARDIOMYOPATHY WITH INOTERSEN (TTR SPECIFIC ANTISENSE OLIGONUCLEOTIDE)
    Dasgupta, Noel Rakhi
    Benson, Merrill
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 811 - 811
  • [6] Treatment of transthyretin cardiomyopathy with a TTR-specific antisense oligonucleotide (IONIS-TTRRx)
    Benson, Merrill D.
    Ackermann, Elizabeth J.
    Monia, Brett P.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2017, 24 : 134 - 135
  • [7] Treatment of ATTR cardiomyopathy with a TTR specific antisense oligonucleotide, inotersen
    Dasgupta, Noel R.
    Benson, Merrill D.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2019, 26 : 20 - 21
  • [8] TREATMENT OF TRANSTHYRETIN AMYLOIDOSIS (ATTR) WITH A TTR-SPECIFIC SECOND GENERATION ANTISENSE OLIGONUCLEOTIDE (ASO)
    Benson, M. D.
    Kincaid, J. C.
    Ackermann, E.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 (02) : 104 - 105
  • [9] Antisense oligonucleotide therapy for TTR amyloidosis
    Benson, M. D.
    Pandey, S.
    Witchell, D.
    Jazayeri, A.
    Siwkowski, A.
    Monia, B.
    Kluve-Beckerman, B.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 53 - 53
  • [10] Antisense oligonucleotide therapy for TTR amyloidosis
    Benson, M. D.
    Pandey, S.
    Witchell, D.
    Jazayeri, A.
    Siwkowski, A.
    Monia, B.
    Kluve-Beckerman, B.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2011, 18 : 60 - 60
12345